Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ORM Narval Mandibular Repositioning Device in the Second-line Treatment of Severe OSAH

NCT01326143 is registered in ClinicalTrials.gov with ResMed as lead sponsor.

NCT NCT01326143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01326143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ORM Narval Mandibular Repositioning Device in the Second-line Treatment of Severe OSAH
Lead sponsor
ResMed
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
February 27, 2019
Enrollment
360 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea syndrome